242 related articles for article (PubMed ID: 17993810)
1. Opportunities and challenges for mesenchymal stem cell-mediated heart repair.
Atsma DE; Fibbe WE; Rabelink TJ
Curr Opin Lipidol; 2007 Dec; 18(6):645-9. PubMed ID: 17993810
[TBL] [Abstract][Full Text] [Related]
2. The roles of mesenchymal stem cells (MSCs) therapy in ischemic heart diseases.
Wang XJ; Li QP
Biochem Biophys Res Commun; 2007 Jul; 359(2):189-93. PubMed ID: 17543286
[TBL] [Abstract][Full Text] [Related]
3. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies.
Martin-Rendon E; Sweeney D; Lu F; Girdlestone J; Navarrete C; Watt SM
Vox Sang; 2008 Aug; 95(2):137-48. PubMed ID: 18557828
[TBL] [Abstract][Full Text] [Related]
4. Concise review: mesenchymal stromal cells: potential for cardiovascular repair.
Psaltis PJ; Zannettino AC; Worthley SG; Gronthos S
Stem Cells; 2008 Sep; 26(9):2201-10. PubMed ID: 18599808
[TBL] [Abstract][Full Text] [Related]
5. Stem cell therapy for ischemic heart disease: where are we?
LaPar DJ; Kron IL; Yang Z
Curr Opin Organ Transplant; 2009 Feb; 14(1):79-84. PubMed ID: 19337151
[TBL] [Abstract][Full Text] [Related]
6. Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation.
Reinders ME; Fibbe WE; Rabelink TJ
Nephrol Dial Transplant; 2010 Jan; 25(1):17-24. PubMed ID: 19861311
[TBL] [Abstract][Full Text] [Related]
7. Amniotic mesenchymal cells autotransplanted in a porcine model of cardiac ischemia do not differentiate to cardiogenic phenotypes.
Sartore S; Lenzi M; Angelini A; Chiavegato A; Gasparotto L; De Coppi P; Bianco R; Gerosa G
Eur J Cardiothorac Surg; 2005 Nov; 28(5):677-84. PubMed ID: 16188450
[TBL] [Abstract][Full Text] [Related]
8. Potential of mesenchymal stem cell therapy.
Dazzi F; Horwood NJ
Curr Opin Oncol; 2007 Nov; 19(6):650-5. PubMed ID: 17906466
[TBL] [Abstract][Full Text] [Related]
9. Improving outcome of transplanted mesenchymal stem cells for ischemic heart disease.
Shi RZ; Li QP
Biochem Biophys Res Commun; 2008 Nov; 376(2):247-50. PubMed ID: 18789897
[TBL] [Abstract][Full Text] [Related]
10. Prepare cells to repair the heart: mesenchymal stem cells for the treatment of heart failure.
Ohnishi S; Nagaya N
Am J Nephrol; 2007; 27(3):301-7. PubMed ID: 17460394
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cell transplantation: a potential therapy for oral lichen planus.
Ding G; Wang W; Liu Y; Zhang C; Wang S
Med Hypotheses; 2011 Mar; 76(3):322-4. PubMed ID: 20961692
[TBL] [Abstract][Full Text] [Related]
12. Forced myocardin expression enhances the therapeutic effect of human mesenchymal stem cells after transplantation in ischemic mouse hearts.
Grauss RW; van Tuyn J; Steendijk P; Winter EM; Pijnappels DA; Hogers B; Gittenberger-De Groot AC; van der Geest R; van der Laarse A; de Vries AA; Schalij MJ; Atsma DE
Stem Cells; 2008 Apr; 26(4):1083-93. PubMed ID: 18203678
[TBL] [Abstract][Full Text] [Related]
13. Cardioprotection and cardiac regeneration by mesenchymal stem cells.
Schäfer R; Northoff H
Panminerva Med; 2008 Mar; 50(1):31-9. PubMed ID: 18427386
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cell therapy for degenerative inflammatory disorders.
Müller I; Lymperi S; Dazzi F
Curr Opin Organ Transplant; 2008 Dec; 13(6):639-44. PubMed ID: 19060556
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of action of mesenchymal stem cells in cardiac repair: potential influences on the cardiac stem cell niche.
Mazhari R; Hare JM
Nat Clin Pract Cardiovasc Med; 2007 Feb; 4 Suppl 1():S21-6. PubMed ID: 17230212
[TBL] [Abstract][Full Text] [Related]
16. Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice.
Ezquer FE; Ezquer ME; Parrau DB; Carpio D; Yañez AJ; Conget PA
Biol Blood Marrow Transplant; 2008 Jun; 14(6):631-40. PubMed ID: 18489988
[TBL] [Abstract][Full Text] [Related]
17. Human mesenchymal stem cells do not differentiate into cardiomyocytes in a cardiac ischemic xenomodel.
Grinnemo KH; Månsson-Broberg A; Leblanc K; Corbascio M; Wärdell E; Siddiqui AJ; Hao X; Sylvén C; Dellgren G
Ann Med; 2006; 38(2):144-53. PubMed ID: 16581700
[TBL] [Abstract][Full Text] [Related]
18. From bone marrow to therapeutic applications: different behaviour and genetic/epigenetic stability during mesenchymal stem cell expansion in autologous and foetal bovine sera?
Tonti GA; Mannello F
Int J Dev Biol; 2008; 52(8):1023-32. PubMed ID: 18956335
[TBL] [Abstract][Full Text] [Related]
19. Controversial issue: is it safe to employ mesenchymal stem cells in cell-based therapies?
Lepperdinger G; Brunauer R; Jamnig A; Laschober G; Kassem M
Exp Gerontol; 2008 Nov; 43(11):1018-23. PubMed ID: 18694815
[TBL] [Abstract][Full Text] [Related]
20. Effect of transplanted mesenchymal stem cells from rats of different ages on the improvement of heart function after acute myocardial infarction.
Wang YQ; Wang M; Zhang P; Song JJ; Li YP; Hou SH; Huang CX
Chin Med J (Engl); 2008 Nov; 121(22):2290-8. PubMed ID: 19080335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
